New Baldness Drug Increased Hair Growth by 539% in Trials
Scientists have developed a serum called clascterone that significantly boosts hair growth—by 539% during clinical trials. This drug requires no injections or oral intake; it is simply applied topically to the scalp. Clascterone works by directly targeting the hormones responsible for hair loss, offering a promising new approach to treating baldness.
Source Gizmodo
This innovation could become the first effective baldness treatment in 30 years. The drug is currently awaiting approval in the European Union and the United States. If successful, the serum could be available on the market by 2027, potentially revolutionizing hair loss therapies.
Such a treatment promises to improve quality of life for many people and represents a major breakthrough in the field of trichology.
